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DFU diabetic foot ulcer 
DPN diabetic peripheral neuropathy 
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Abstract  
This thesis integrates a series of previously published papers centring around three 
interrelated themes addressing the complex relationship between diabetic foot ulcers 
(DFU) and physical activity engagement.  The three foci of the thesis include: 1) 
‘offloading’ DFU via specialized footwear that limit the application of physical stress 
to ulcers during weight bearing activity in order to promote healing; 2) monitoring and 
managing physical activity engagement of both patients at risk for DFU and patients 
with active DFU; 3) the heightened risk of falls in individuals at risk for DFU.  A 
cohesive underlying foundation of the body of work contained within this thesis is an 
effort to help care providers and patients achieve better physical activity profiles. 
Offloading diabetic feet refers to the redistribution of physical stress away from sites 
at risk for or with active DFU.  Thus, it is important to both prevent DFU but also to 
heal active DFU.  This thesis includes two publications pertaining to the objective 
measurement of patient adherence to offloading modalities as well as two 
publications regarding the biomechanical assessment of devices used to offload 
DFU.  The need for offloading is necessitated by the fact that individuals with DFU 
engage in weight bearing physical activity that can inflict physical trauma beyond the 
tolerance of the soft tissue of their feet, however, the relationship between physical 
activity and the formation as well as healing of DFU is not fully understood.  A series 
of five publications concerning physical activity within patients with, or at risk for DFU 
are included in this thesis: two focus on improved monitoring of physical activity and 
three focus on safely increasing physical activity engagement.  Due to a number of 
interconnected factors, individuals at risk for DFU are also at high risk for falling.  
The final three publications included in this thesis are devoted to falls risk.  
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Chapter 1: Introduction  
An alarming 9.3% of the global population, equivalent to 463 million people, 
was estimated to have diabetes in 2019 and that percentage is expected to continue 
climbing for the foreseeable future1. Unfortunately there are numerous serious 
complications for which patients with diabetes are at risk.  One of the most insidious 
complications is diabetic foot ulcers (DFU), despite the fact that these wounds are a 
relatively neglected complication2.  Recent estimates suggest that 19-34% of 
individuals with diabetes will develop a DFU within their lifetime3.  The five year 
survival rate for persons with a diabetic foot ulcer is ~50-60%2 which is worse than 
many common types of cancer such as breast and prostate4.  In addition to having a 
reduced life expectancy, patients that develop a DFU are at significant risk for a 
subsequent lower extremity amputation5-9.  Patients with diabetic foot disease have 
actually reported fearing a major lower extremity amputation more than death10.  
DFU are exceptionally difficult to heal which helps explain why they precede 84% of 
amputations in patients with diabetes11.  Another marker of the burden of DFU is the 
tremendous fiscal cost of treating them.  In the United States, approximately one-
third of $237 billion in direct costs for diabetes care in 2017 were associated with foot 
disease care12.  In England 0.8-0.9% (£837-962 million) of the National Health 
Service budget is tied to care for ulcerations and amputations in people with diabetes 
and >90% of those costs are related to DFU13.   
There are a number of diabetic complications that predispose individuals 
towards developing DFU14-17, however, the loss of ‘protective sensation’ due to 
diabetic peripheral neuropathy (DPN) is commonly the primary factor.   DPN induced 
loss of sensation allows affected individuals to wear a hole in the surface of their feet 
without feeling any pain, similarly to wearing a hole in a pair of socks18,19.  Although 
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DFU sometimes form in response to acute trauma such as extreme temperature 
exposure or puncture of the plantar tissue by a foreign body, they typically form in 
response to the cyclical application of physical stress to the feet during weight-
bearing physical activity (PA)18.  Within this perspective, plantar tissue stress has 
been defined as “the accumulation of all mechanical stresses on an area of plantar 
foot tissue from all weight-bearing activity over time” (p. 869)20.  Key factors in 
quantifying this stress include the vertical loading (pressure), horizontal loading 
(shear) and the volume of stress (PA).  Mueller and Maluf laid out a ‘physical stress 
theory’ that presents how tissue will respond to a continuum of varying amounts of 
stress21.  Negative outcomes are associated with both the low and high ends of the 
continuum.  On the high end, the absence of pain in neuropathic feet allows diabetic 
individuals to cross the threshold into the excessive stress region of the continuum 
without their knowledge.  This placement of excessive stress on the feet in turn leads 
to a breakdown of plantar tissue and formation of a diabetic foot ulcer.   
1.1: Offloading Diabetic Foot Ulcers  
Devices that offload active ulcers redistribute stress away from DFU locations 
to other plantar regions of the foot and in some cases to the leg as well.  The best 
evidence to date from randomized controlled trials, indicates irremovable knee high 
devices (either total contact casts or prefabricated cast walkers) yield the best 
healing outcomes22-24.  Despite irremovable offloading options being considered the 
‘gold standard’ for DFU, multiple studies have found they are used minimally by 
practitioners25-27.  One of the reasons reported for not using irremovable knee-high 
devices is patients’ lack of tolerance for the devices25,26.  Some of the factors 
influencing patient tolerance include interference with sleep, self-care, choice of 
clothing, and mobility/balance.  Intervention related barriers to providers’ use of 
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irremovable knee-high devices include secondary complications such as new ulcers 
and falls, as well as the cost, time, and skill required to dispense the devices25,26.  A 
final barrier to the use of irremovable knee-high devices are wound related barriers, 
such as limited access to wounds for monitoring healing and conducting dressing 
changes25,26. In common practice offloading devices such as removable cast 
walkers, specialty shoes and felted foam are used more commonly to offload DFU25-
27.  Chapter 2 of this thesis presents four publications28-31 centred upon the use of 
removable offloading devices to treat DFU.   
1.2: Monitoring and Managing Physical Activity   
Although the formation of ulcers on neuropathic feet have long been attributed 
to the physical stress imparted during weight bearing activity32, attempts to quantify 
the stress patients place on their feet in the real world has been a more recent 
advent.  Initial forays into objectively studying the association between PA and DFU 
utilized pedometers to record the number of steps patients took per day33,34.  While 
these initial studies measuring step counts represented a substantial advance over 
self-reports of PA, these studies still presented a limited assessment of the cycles 
and duration of stress individuals exposed their feet to over the course of a day.  
Chapter 3 of this thesis includes two publications35,36 regarding the advancement of 
methodologies used to quantify PA engagement in association with DFU.  The 
chapter also includes three additional publications37-39 regarding efforts to help 
patients with diabetic foot disease to engage in safe levels of PA from which they 
can derive the benefits of PA without excessively stressing their feet.    
1.3: Falls in Individuals at Risk for Diabetic Foot Ulcers  
 Like DFU, accidental falls present a tremendous global burden.  The World 
Health Organization (WHO) estimated 283,000 people died due to falls in 200040.  
Page | 11 
 
The WHO also noted that in all regions of the world adults >70yrs have a significantly 
higher fall-related mortality rate than younger persons.  As the global population 
aged, the estimated number of deaths due to falls increased to 646,000 in 2018 and 
by that date the annual number of falls requiring medical attention was ~37.3 
million41.  Chapter 4 of this thesis is centred on the unfortunate association between 
diabetic foot disease and falls in older adults.  The first publication of the chapter 
discusses how factors such as decreased sensorimotor function, musculoskeletal 
deficiencies, pain, and therapeutic footwear can increase the risk for falling by older 
adults with diabetes42.  The next publication is associated with a study that evaluated 
an intervention intended to treat the fall-risk factor of DPN43.  The final publication of 
the chapter presents a study that assessed the association between DPN and fear of 
falling44.   
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Chapter 2: Diabetic Foot Ulcer Offloading Publications 
 
2.1: Critical Account of Offloading Publications  
Although offloading areas of the foot that are prone to high physical stress via 
specialized footwear and devices is critical to both the prevention of new DFUs and 
the healing of active DFUs22,45, the offloading publications in this thesis focus upon 
offloading active wounds.  The first two offloading publications addressed a prior gap 
in the understanding of why removable offloading devices have poorer healing 
outcomes.  Despite removable cast walkers (RCW) having been shown to offload 
DFU as well as total contact casts46,47, RCW have consistently provided poorer 
healing outcomes47,48.  Based on the results of these past studies it was assumed 
that individuals that were provided RCW were choosing not to wear their devices 
during all weight bearing activity.  Although some information regarding patient 
adherence could be gathered via patients self-reporting, there is a high likelihood 
that some patients will inflate their reported adherence levels49.  Therefore, a means 
to objectively monitor adherence was validated within Publication 1 of this thesis28.   
Publication 1’s methodology utilized a waist worn accelerometer to monitor 
PA engagement.  A secondary accelerometer that was time synchronized to the first 
accelerometer, was affixed to the offloading device (RCW).  This secondary 
accelerometer was concealed upon the RCW and participants were not made aware 
of its presence.  Adherence was determined by whether the RCW’s accelerometer 
registered movement at the times when the waist mounted device registered PA.  
Although a large number of adherence data samples were collected in Publication 1 
(1,851 samples) the data was limited in that it was collected from a single subject 
and relied on a single accelerometer model.  Future studies aimed at replicating the 
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findings of Publication 1 would benefit from the use of multiple subjects and the 
incorporation of multiple models of accelerometers to confirm whether the results 
remain consistent across varied subjects and accelerometers.   
Publication 1 served as a precursor to Publication 2 and its adherence 
monitoring methodology was utilized in the study associated with Publication 2 of this 
thesis29.  Publication 2 presented the first study to look at the association between 
DFU healing and offloading adherence in which adherence was treated as a 
continuous variable.  Previous research had dichotomized adherence as either 
absolute (use of irremovable device) or partial (use of removable device).  In 
contrast, Publication 2’s study objectively demonstrated when offloading adherence 
is considered as a continuous variable it is positively associated with DFU healing.  
The best predictor of non-adherence the study identified was patients’ (N=79) level 
of self-reported postural instability, hence linking offloading adherence with the risk 
for falls.  In considering the work of Publication 2 (and Publication 1) in today’s 
environment, it is worth noting significant advances have been made in activity 
monitoring.  Were this work to be repeated, newer monitors that capture a much 
more granular detail of physical activity engagement could be used to provide 
greater insight into what DFU patients are doing both with and without use of their 
offloading devices.  For example, the activity monitors utilized in chapter 3 of this 
thesis provided continuous monitoring of body posture allowing for assessment of 
how much time the feet are loaded while standing and even during periods of sitting. 
The next two offloading publications of this thesis dealt with efforts to improve 
the patient experience with RCW which in turn may lead to improved DFU healing.  
These studies were undertaken in recognition of the following facts: 1) RCW are 
used more often than irremovable devices; 2) knee high RCW provide the same 
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functional offloading benefit to DFU as irremovable knee high devices; 3) RCW’s 
poorer DFU healing outcomes are associated with patients choosing not to 
adherently use them.  The first of these studies investigated whether height of RCWs 
impacted offloading capacity30.  Individuals at risk for DFU (presence of DPN) have 
been shown to be physically deconditioned50.  As RCW are quite heavy relative to 
normal footwear, one would expect DFU patients to have difficulty walking while 
wearing RCW. Publication 3 of this thesis found knee high and ankle high RCW 
provided similar offloading benefit to the forefoot that was superior to a shoe height 
RCW30.  The study also provided some preliminary data suggesting balance may 
have been better in the ankle high RCW than in the knee high RCW.  The second of 
these studies investigating the potential to improve the patient experience with 
offloading modalities considered two design factors for RCW31.  As in the first study, 
it compared ankle high and knee high walkers.  In addition to looking at height/size 
as a factor, Publication 4 of this thesis also considered the imposed limb length 
discrepancy that the thick rocker bottom soles of RCW induce.  The study 
investigated the use of an external shoe lift for the limb contralateral to the limb using 
the RCW.  The study found the best gait and self-reported comfort outcomes were 
associated with the ankle high RCW paired with a contralateral shoe lift.  Future 
studies are needed to confirm whether provision of an ankle high RCW paired with a 
contralateral shoe lift leads to greater offloading adherence and DFU healing than 
provision of a knee high RCW.   
 
2.2: Publication 1  
A Method for Assessing Off-loading Compliance (2009)   
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2.2.1: Publication 1 Aim 
 The aim of the study associated with this publication was to validate a method 
for objectively monitoring patient adherence to offloading devices. 
2.2.2: Publication 1 Summary 
 A single adult subject’s adherence to the use of a RCW was assessed during 
waking hours over four consecutive days (approximately 15.5 hours/day).  The 
subject did not have a DFU and was instructed to alternate use of the RCW and 
standard footwear several times a day.  Each time the RCW was donned or doffed, 
the subject recorded the time of the event in a diary.  The objective adherence 
monitoring methodology relied on the use of two accelerometry-based activity 
monitors.  One monitor was worn on the subject’s clothing at hip level per the 
device’s (Lifecorder Plus; Suzuken Co Ltd, Nagoya, Japan) standard use directions.  
Each of the activity monitors logged intensity of PA engagement in two minute 
epochs and the two devices were time synchronized.  PA recorded by the hip worn 
monitor was coded as adherent/non-adherent based upon whether the RCW monitor 
registered movement at the same time the hip monitor registered movement.  The 
monitoring period consisted of 1,851 two minute epochs and PA was registered 
during 591 of the epochs.  Three different adherence processing schemes were 
evaluated.  The first relied on a simple on/off principal- if the RCW registered any 
activity at the same time activity was registered by the hip monitor, the subject was 
considered to have been wearing the RCW during the activity.  The other two 
methods had set ratio cut-offs for assigning adherence. Method two assigned PA as 
RCW adherent if the RCW monitor’s PA for a two minute epoch was greater than 
half of the value recorded at the hip.  The third method assigned PA as RCW 
adherent if the RCW monitor’s PA for a two minute epoch was greater than the value 
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recorded at the hip.  PA intensity values were given positive values if the activity had 
been coded as RCW adherent and the values were negative values if the activity 
had been coded as non-adherent.  A repeated-measures ANOVA was conducted 
with the four compliance coded PA data sets (1 diary coded and 3 variants coded via 
RCW monitor) and followed by intraclass correlation calculations of diary coded PA 
with the three RCW monitor methods.  The second methodology of processing the 
RCW monitor data proved the most accurate, as that data set did not significantly 
differ from the diary coded data and had a high intraclass reliability value of 0.93.   
2.2.3: Publication 1 New Knowledge Gained  
 The study found the dual activity monitor methodology for objectively 
monitoring offloading adherence was valid.  Having an objective means of measuring 
adherence is advantageous over self-reporting for two reasons.  Self-reporting can 
be biased by patient recall error.  Recall error could be substantial as DFU typically 
take at least several weeks to heal and often require a period of months to heal.  
Another potential source of bias with self-reported adherence is intentional errors in 
reporting.  A patients’ desire to please their care providers may result in the patient 
inflating their reported RCW adherence.  The adherence monitoring methodology 
validated in this publication can be of benefit both to future research as well as for 
patient management.   
2.3: Publication 2 
The Role and Determinants of Adherence to Offloading in Diabetic Foot Ulcer 
Healing: a Prospective Investigation (2016) 
Page | 17 
 
2.3.1: Publication 2 Aim 
 The primary aim of the study associated with this publication was to determine 
whether objectively monitored offloading adherence was associated with DFU 
healing.  The secondary aim was to identify determinants of offloading adherence. 
2.3.2: Publication 2 Summary 
 The study was a prospective multicentre investigation of DFU patients in the 
UK (n= 46) and US (n = 33).   All patients were provided a removable offloading 
device and told to wear the device during all weight bearing activity.  Most patients 
(77%) received removable cast walkers.  Adherence was monitored via the 
methodology validated in Publication 1 of this thesis28.  However, the activity monitor 
placed on offloading modality was concealed from easy identification.  In order to 
limit the likelihood of the Hawthorne effect (altering behaviour in response to being 
aware one is being observed) impacting adherence results, participants were not 
notified that offloading adherence was being monitored.  Offloading adherence and 
wound healing were monitored for a period of 6 weeks.  If wound healing occurred 
prior to 6 weeks, adherence monitoring was halted at the study visit at which the 
wound was determined to have fully healed.  Wound healing was assessed by 
making digital planimetry measurements of digital wound photographs.  Patient 
demographics were collected at baseline and participants also completed three 
psychological assessments: Neuropathy and Foot Ulcer Quality of Life (NeuroQol) 
scale51, Revised Illness Perception Questionnaire (IPQ-R)52, depressive symptoms 
7-item subscale of Hospital Anxiety and Depression Scale (HADS)53.  Participants’ 
wounds significantly decreased in size over the course of the study (230±288 mm2 
vs. 106±155 mm2, p<0.001) and 19 participants (24%) achieved complete wound 
closure.  The mean monitoring period was 35±10 days.   
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2.3.3: Publication 2 New Knowledge Gained  
 The primary aim of Publication 2 was achieved with offloading adherence 
being found to significantly predict end of study wound size.  Other predictors of final 
wound size were baseline wound size and country of residence (UK participants 
achieved greater healing).  Although baseline wound size being predictive of end of 
study wound size was not surprising, the difference between UK and US participants 
was not anticipated.  An explanation was not initially noted in Publication 2, however, 
upon further refection the greater use of healing sandals in the US was identified as 
likely contributing to this difference.  Most of the participants in the study used knee-
high removable cast walkers, however, 13 participants used the less efficacious 
option of healing sandals24.  The use of sandals was much more prevalent (n=10 vs. 
n=3) in the US.   Publication 2 was also able to achieve its secondary aim of 
identifying determinants of offloading adherence.  Lesser self-reported postural 
instability, larger and more severe (University of Texas classification54) baseline 
ulcers, higher foot pain and more severe neuropathy were all predictive of greater 
adherence.   
There is one notable difference between the findings of Publication 2 and prior 
research regarding RCW adherence.  In 2003, Armstrong et al. published the results 
of a single site (Tucson, Arizona USA) study that assessed RCW adherence 
independently of wound healing34.  They found their cohort of patients only wore their 
RCW during 28% of their daily PA.  However, in Publication 2 participants adherently 
used their offloading devices during 59±22% of their PA.  The difference between the 
two studies may in part be due to regional and demographic differences in 
adherence (which is plausible considering the results of Publication 2) as well as a 
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general improvement in patients’ offloading adherence over the intervening time 
between the two studies.   
2.4: Publication 3  
Impact of Strut Height on Offloading Capacity of Removable Cast Walkers (2012) 
2.4.1: Publication 3 Aim 
The primary aim of the study associated with this publication was to determine 
whether altering the height of a removable cast walker altered the offloading capacity 
of the device.  Gait kinematics while walking in the devices were assessed as 
secondary exploratory variables.   
2.4.2: Publication 3 Summary 
Eleven participants with DPN were recruited.  Participants had to be able to 
walk without the use of an assistive device such as a cane and could not have an 
active DFU at the time of their participation.  Each participant completed walking 
trials in three removable cast walker options and a control condition of bilateral 
athletic shoes.  The removable cast walkers included a knee-high option (DH 
offloading Walker, Össur Americas, Foothill Ranch, CA), an ankle-high option 
(Equalizer Walker, Össur Americas, Foothill Ranch, CA) and a shoe option.  The 
ankle-high and shoe options only differed from the knee-high walker in regards to the 
height of the devices’ rigid struts running up the sides of the leg and the height of the 
soft goods that extended up the leg.  The same offloading insole was utilized with 
each cast walker and each walker utilized the same rocker bottom outsole.   
Outcome measures were collected while conducting a 20m walking trial in 
each footwear condition.  The order of footwear was randomized for each participant.  
In-shoe pressure insoles (Pedar-X; Novel, Munich, Germany) collected foot loading 
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data at 100Hz.  Masking software was utilized to identify peak pressure and pressure 
time integral values for 4 forefoot regions that commonly ulcerate.  Repeated 
measures ANOVAs with main effects of footwear and foot region were used to 
analyse the peak pressure and pressure time integral data.  Gait kinematics 
variables were collected at 200Hz via an inertial measurement unit system (Physilog, 
BioAGM, CH).  One-way repeated measures ANOVAs were used to compare 
kinematic parameters while walking in the varied footwear.   
There was a significant interaction between footwear and foot region for peak 
pressure and pressure time integral.  Therefore, the effect of footwear within each 
region as assessed via least significant difference post hoc analyses.  Each of the 
removable cast walker options yielded statistically significant lower peak pressure 
and pressure time integral values at each of the four foot regions.  The ankle-high 
and knee-high removable cast walkers generally yielded significantly lower pressure 
values than the shoe cast walker.  Although there were some significant pressure 
differences between the ankle-high and knee-high cast walkers, overall their 
offloading performance was quite similar.  The only statistically significant kinematic 
outcome was a 12% decrease in velocity while walking in the knee-high removable 
cast walker relative to the standard shoes (p=0.028).  Although differences were not 
significant, there was a trend of the ankle-high cast walker yielding a smaller range 
of centre of mass rotation (18% medial/lateral and 22% anterior/posterior) than the 
knee-high cast walker.   
2.4.3: Publication 3 New Knowledge Gained  
 The offloading capacities of the ankle-high and knee-high removable cast 
walkers were similar to that observed in prior cast walker research46, however, the 
finding that the ankle-high and knee-high cast walkers were similar to one another 
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was novel.  Both provided greater offloading than the shoe cast walker option.  They 
also shared a functional difference to the shoe cast walker.  Both the ankle-high and 
knee-high RCW fixated the ankle joint. They did so via rigid medial and lateral struts 
that ran along the ankle and were used to prevent ankle motion.  In contrast, the 
shoe cast walker was lacking such struts and allowed normal plantarflexion and 
dorsiflexion at the ankle joint.  Therefore, preventing normal heel-toe walking by 
locking the ankle joint is necessary to achieve maximum forefoot offloading with a 
cast walker.  
 While the necessity to immobilize the ankle joint was ascertained by this 
study, it did not identify a need for removable cast walkers to extend up the full 
length of the shank. The ankle-high cast walker that extended only slightly above the 
ankle provided similar offloading to the knee-high device that extended up to the 
lower portion of the knee.  In the case of the specific two devices considered in this 
study (ankle-high: Equalizer Walker, Össur; knee-high: DH Offloading Walker, 
Össur), the ankle-high device was 20% lighter than the knee-high device. As 
individuals with DFU are physically deconditioned50, this reduction in weight would 
be expected to facilitate gait and movement of DFU patients and may lead to 
improved device adherence. The exploratory kinematic outcomes in the present 
study tend to support this theory.  The fact that participants walked significantly 
slower in the knee-high cast walker compared to standard shoes, however, did not 
walk significantly slower in the ankle-high cast walker suggests the participants were 
able to more easily ambulate in the ankle-high walker than the knee-high walker. 
Although the study was limited by simple straight-ahead walking trials with no 
obstacles or other challenges, a trend was identified in the centre of mass data that 
suggested potentially improved stability in the ankle-high walker relative to the knee-
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high device.  However, the simple walking task and lack of a priori sample size 
estimation, prohibited the ability to make a conclusive determination as to whether 
the participants were more stable while walking in the ankle-high device relative to 
the knee-high device.   
2.5: Publication 4  
Decreasing an offloading device’s size and offsetting its imposed limb length 
discrepancy leads to improved comfort and gait (2018) 
2.5.1: Publication 4 Aim 
The aim of this study was to determine whether the size of removable cast 
walkers and limb length discrepancy they typically induce, negatively impact comfort 
and gait of diabetic individuals.   
2.5.2: Publication 4 Summary 
Twenty-five adults with diabetes (type 1=2; type 2=23) and at risk for DFU 
were recruited. In order to avoid the possibility of study activities causing a 
deterioration in an active DFU, individuals with an active DFU were excluded from 
participating.  Participants were all able to walk without the need for an assistive 
device such as a cane or crutches.  Additionally, none of the participants had 
previously received care for a limb length discrepancy.  Each participant “completed 
walking trials under five different conditions: 1) bilateral standardized athletic shoes 
(New Balance, Boston, MA), 2) a standardized athletic shoe on one foot and an 
ankle-high RCW on the other foot, 3) a standardized athletic shoe plus an external 
shoe lift (Evenup LLC, Buford, GA) on one foot and an ankle-high RCW on the other 
foot, 4) a standardized athletic shoe on one foot and a knee-high RCW on the other 
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foot, and 5) a standardized athletic shoe plus an external shoe lift on one foot and a 
knee-high RCW on the other foot” (p. 1401)31.   
During each 20m walking trial spatial/temporal parameters of gait (i.e. 
velocity, stance time, base of support) were captured by a 7.3m long instrumented 
carpet (GAITRite; CIR Systems Inc., Franklin, NJ) that was positioned in the middle 
of the walkway. Additionally, plantar pressure loading of the feet was captured by 
instrumented insoles (Pedar-X; Novel, München, Germany).  Participants were asked 
to walk as they normally would during each trial and no effort was made to control 
speed between trials. Although variations in speed would be expected to alter foot 
pressures, the purpose of the study was to determine whether gait parameters 
changed under the varied footwear conditions.  Following the completion of all of the 
walking trials, participants were asked to rate the comfort of each footwear condition 
via a visual analog scale.  
Comfort data was analysed by a one-way (footwear condition) repeated 
measures ANOVA.  The participants perceived significant differences in comfort 
(p<0.005; effect size = 0.30). Both of the offloading trials in which the lift was not 
used were less comfortable than the bilateral athletic shoes condition.  Neither of the 
offloading conditions in which the external shoe lift was used significantly differed 
from the bilateral athletic shoes.  
The gait and plantar pressure data collected in the four offloading conditions 
were normalized by the values collected in the bilateral athletic shoes condition.  The 
normalized data was then assessed by a two-way (cast walker height x contralateral 
limb lift use) repeated measures ANOVA.  Mean walking velocity was significantly 
reduced (p=0.006; effect size=0.27) with use of the knee-high cast walker.  Use of 
the contralateral lift did not impact walking velocity.  However, the use of the lift did 
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impact variability in walking velocity (step-by-step).  All offloading conditions had 
higher variability in walking velocity relative to athletic shoes, but the use of the lift 
resulted in significantly less variability than offloading trials in which the lift was not 
used.  Cast walker height did not impact variability in step velocity. Stance time for 
the limb using the cast walker was significantly affected by lift use (p=.011; effect 
size=0.25) but not by the height of the cast walkers (p=.095).  All offloading 
conditions had higher stance time for the offloaded limb than when walking in 
bilateral athletic shoes, however, the increase was smaller when the lift was used.  
Base of support for the limb using the cast walkers was not affected by walker height 
or contralateral limb lift use.  
Numerous significant findings were found between footwear conditions in 
regards to the plantar pressure data.  The use of the contralateral lift resulted in 
higher pressures in three of four forefoot regions assessed on the offloaded foot.  
The difference at the medial forefoot (1.6%) was non-significant but the differences 
at the intermediate forefoot (4.5%), lateral forefoot (5.6%) and hallux (3.6%) were 
significant.  Similarly, the height of the cast walker significantly affected three of the 
four forefoot regions for the offloaded foot.  The knee-high walker resulted in greater 
offloading at the medial forefoot (8.1%), intermediate forefoot (8.6%) and lateral 
forefoot (4.8%).  For the non-offloaded limb, the use of the lift had an opposite effect 
to that seen on the offloaded limb.  Use of the lift resulted in significantly reduced 
pressure throughout the forefoot of the foot using the lift (medial forefoot= 4.2%; 
intermediate forefoot= 7.6%; lateral forefoot= 11.9%; hallux= 6.3%).  Cast walker 
height had no significant effect on forefoot loading for the non-offloaded limb.  
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2.5.3: Publication 4 New Knowledge Gained 
 Despite being considered the gold-standard for offloading DFU55, knee-high 
irremovable devices (total contact casts and non-removable walkers)  are not 
routinely used by clinicians25-27.  Limited tolerance by patients is one of the reported 
reasons why knee-high irremovable devices are not more commonly utilized25.  
Limited tolerance also inhibits the benefit of removable offloading devices as multiple 
studies have found adherence with such devices to be low29,34.  Publication 2 of this 
thesis identified self-reported instability as a predictor of non-adherence and this 
finding was confirmed by an additional study regarding reasons for non-adherence to 
self-care by people with DFU56.  The substantial weight of knee-high devices and 
their imposition of an artificial limb length discrepancy are additional factors that may 
negatively influence offloading adherence57.  Publication 4 sought to determine 
whether reducing a cast walker’s size/weight and preventing it from causing a limb 
length discrepancy would positively impact the user experience by improving comfort 
and gait.   
 The varied offloading conditions did result in differences in perceived comfort 
as well as a number of gait parameters.  The study participants reported the ankle-
high cast walker paired with the contralateral lift as the most comfortable offloading 
condition and the comfort rating for this condition did not differ from that reported for 
walking in bilateral athletic shoes.  The least comfortable offloading condition was 
the knee-high cast walker without a contralateral lift.  A previous study58 of custom-
made footwear for preventing DFU reported comfort as the highest priority for 
patients when determining footwear usability, thus the comfort findings in the present 
study likely have implications for adherence levels with the varied offloading options.  
The current study’s findings regarding gait parameters also have likely implications 
Page | 26 
 
for adherence.  Prior studies have noted older adults with diabetes walk with slower 
velocities as fear of falling increases44,59.  Similarly, Reeves et al.60 found gait 
velocity to be negatively correlated with self-perceived unsteadiness.  Dingwell et al. 
postulated that reductions in walking speed by individuals with diabetic neuropathy 
are a compensatory strategy61. In addition to absolute walking speed, greater 
variability in speed has been found to be a discriminating factor between those older 
adults that do or do not fall62.  Collectively this prior research suggests the gait 
velocity findings in the present study may be due to participants feeling more stable 
in the ankle-high cast walker with contralateral limb lift offloading condition.  If that is 
the case, a corresponding increase in patient adherence would be expected if 
patients with active DFU were offloaded in this manner in contrast to patients 
provided with a knee-high cast walker without a contralateral limb lift.   
 While this study found comfort and gait parameters were improved with the 
ankle-high walker and contralateral limb lift condition, the greatest reduction in 
plantar pressure for the offloaded limb was noted in the knee-high walker without 
contralateral lift condition.  As the study was not a prospective study of patients with 
active DFU, it was not possible to determine the ultimate impact of the varied 
offloading conditions on wound healing.  However, it is postulated that if the ankle-
high walker paired with a contralateral lift does lead to increased adherence in DFU 
patients, the increased adherence will outweigh the lesser amount of offloading 
provided by this offloading option.  Future randomized controlled trials in patients 
with active DFU will be required to test this hypothesis.  
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Chapter 3: Monitoring and Managing Physical Activity Publications  
3.1: Critical Account of Physical Activity Publications  
This PhD thesis includes the first study to objectively quantify the amount of 
time individuals at risk for DFU spend standing63.  The study associated with 
Publication 5 found that participants spent twice as much time standing each day as 
they did walking, thereby implying future studies and interventions regarding the 
association between DFU and PA should not be limited to solely tracking step 
counts.  One of the surprising findings of the prior initial investigations that assessed 
the association between PA and DFUs was that patients at risk for DFU took the 
majority of their total daily steps inside of their homes33. This finding was made by 
merging step counts from a pedometer with self-report diaries of time spent away 
from home.  Utilizing self-reports to capture places visited by patients in future 
investigations and interventions regarding the association between environment and 
PA engagement, poses the risk of both unintentional and intentional errors in 
reporting.  This PhD thesis presents a publication that addresses this limitation36.  
Publication 6 reviews the development and application of a methodology for 
monitoring location-specific PA via pairing GPS data with accelerometry based PA 
data.  The capacity to continuously and objectively monitor how PA patterns vary 
according to a person’s environment will greatly aid future work addressing the 
association between weight-bearing activity and DFUs.    
In addition to presenting work focused on improving the monitoring and 
quantification of PA engagement by those with or at risk for DFU, publications 7-9 of 
this thesis cover efforts to help these individuals appropriately manage their levels of 
weight-bearing PA.  The European Association for the Study of Diabetes and the 
American Diabetes Association are in agreement that “…efforts to improve diet and 
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exercise remain the foundation of all glycemic management (p. 26)”64.  Although 
meeting activity guidelines is a common challenge throughout the entire population 
of persons with diabetes, those individuals at risk for diabetic foot ulcers (DFUs) are 
less likely to engage in PA, due in part to the unique barriers they report (e.g., 
distress about developing a DFU or needing an amputation)65-67.  Patient and 
provider fears about DFU developing in association with efforts to increase weight-
bearing PA are understandable in light of the fact that DFUs typically form in 
response to repetitive trauma produced by weight bearing PA18,19.  However, in a 
departure from past guidelines, the most recent joint guidelines from the American 
Diabetes Association and the American College of Sports Medicine recognizes that 
moderate walking does not increase risk for DFU by individuals with peripheral 
neuropathy68. In fact, there is growing support in the literature for the belief that 
controlled increases in PA can reduce DFU risk57,69-71.   
 Therefore there is a need for identifying means of safely improving PA profiles 
of persons at-risk for DFU.  Although persons at-risk have commonly been excluded 
from exercise and PA interventional studies in the past67,  there have been some 
exercise studies done within this population72-75.  While these limited past studies 
have shown potential benefits, the interventions they employed would be costly to 
widely implement both from fiscal and time perspectives as they relied on 1-6 in 
person visits per week and are generally not covered by insurance.  In addition to 
often being cost prohibitive for large scale implementation, these supervised activity 
interventions have generally suffered from a lack of behaviour change strategies that 
may be necessary to promote maintenance.   
Publication 7 of this thesis focused on the use of a technology-based (activity 
monitors and text messaging) PA intervention for individuals at-risk for DFU37.  The 
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intervention was intended to gradually increase participants’ PA in order to improve 
their health without causing a DFU in response to the concerted effort to increase 
activity. This initial pilot study found participants had a small improvement in diabetes 
control (0.33% reduction in HbA1c; Cohen’s d= 0.23) and a moderate increase in PA 
(882 steps/day; Cohen’s d=0.66).   
As alluded to when previously discussing this thesis’ offloading studies, 
devices used to treat active DFU can make walking difficult.  Furthermore, extra 
caution is warranted in considering how much load is acceptable for a foot with an 
active DFU.  Past research has shown that high peak plantar pressures are 
associated with longer DFU healing times76.  Even when gold standard offloading 
devices are provided to patients it is not clear how much upright weight bearing PA is 
appropriate for individuals with active DFU77.  With this in mind, this thesis presents 
two studies regarding the evaluation of a cycling cleat that was designed to allow 
individuals with a forefoot DFU to participate in exercise incorporating the lower 
extremity without exposing the DFU to stress of sufficient magnitude to inhibit 
healing.  The cleat was similar in design to a RCW and its interface with the bicycle 
was intended to limit foot loading to the heal region of the foot.   
The first study of the cleat (Publication 8) included healthy participants and 
served to confirm that the cleat did significantly offload feet while cycling38.  In 
progressing towards use by patients with active DFU, the second study (Publication 
9) involved individuals at-risk for DFU39.  In addition to confirming the offloading 
capacity of the cleat in a population more representative of patients with active DFU, 
this secondary study found increased perfusion to the distal portion of the foot 
following cycling with the cleat.  This increased blood perfusion is important as it 
implies that use of the cleat may not only provide general exercise induced health 
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benefits but may actually aid healing of DFU as blood perfusion to these wounds is 
often insufficient.  One likely challenge to future large scale use of the device, is 
practical limitations of patients coming into clinical/physiotherapy settings for regular 
cycling sessions.  Both Publication 8 and 9 were limited to evaluating the cleat in a 
highly controlled research environment in which research personnel assisted 
participants in their use of the cleat.  Future work should consider means of feasibly 
implementing the cycling exercise safely in patients’ homes.   
 
3.2: Publication 5  
The Importance of Time Spent Standing for those at Risk of Diabetic Foot Ulceration 
(2010) 
 
3.2.1: Publication 5 Aim 
This study sought to more comprehensively quantify weight bearing activity 
conducted by individuals at risk for DFU than had been previously possible.  In 
addition to capturing the traditional metric of steps taken by participants, the duration 
of time spent standing, sitting and lying down was also measured.   
3.2.2: Publication 5 Summary 
 Thirteen participants at risk for DFU (presenting with DPN) and a mean age of 
59 ± 8 years were recruited.  Neuropathic status was defined as the inability to 
detect a 10 gram Semms Weinstein Monofilament at one or more of the following 
locations: hallux, 1st metatarsal head, 3rd metatarsal head, and 5th metatarsal 
head78.  Participants were given an undershirt that contained a padded pouch at a 
position corresponding to their sternum.  The pouch held a novel triaxial 
accelerometer based activity monitor (PAMSys; BioSensics, Cambridge, MA USA) 
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that was capable of continuously tracking body posture in addition to gait data79.  
Participants were asked to wear the undershirt and associated activity monitor 
continuously for 48 hours.  They were advised to only take it off while bathing.  Data 
was sampled continuously at 50Hz and periods when the undershirt and monitor 
were not worn were automatically identified during data processing by identifying 
periods of minimal acceleration amplitudes.  Over the course of the 48hr monitoring 
period, participants only removed the undershirt and sensor for 17.5 ± 29.9min.    
3.2.3: Publication 5 New Knowledge Gained  
 Prior to this study, objective investigations into PA profiles of individuals at risk 
for DFU were limited to measuring how many steps participants took80,81.  This study 
found that participants spent 13.5 ± 5.3% of their time standing, 6.1 ± 
3.1% walking, 37.3 ± 6.3% sitting, and 44.3 ± 8.1% lying down per day.  Thus 
previous investigations concerned with mechanistically understanding how stresses 
applied to the feet during weight bearing activity lead to DFU, had likely failed to 
capture two-thirds of the participants’ weight-bearing time by failing to measure 
standing time.  In addition to being the first study to quantify how much time patients 
at risk for DFU spend standing (as well as sitting and lying down), it also provided a 
more detailed description of participants’ walking profiles than was possible in prior 
studies.  Statistics pertaining to individual bouts of walking were reported in 
Publication 5.  The maximum duration walking bout for each participant was on 
average only 3.9 ± 3.8min, which equated to 422 ± 403 steps.  Surprisingly, the 
correlation between participants’ total number of steps per day and the duration of 
their longest continuous walking episode was not significant (r = 0.32, P = 0.30).   
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3.3: Publication 6 
Monitoring Location Specific Physical Activity via Integration of Accelerometry and 
Geotechnology within Patients with or at-risk of Diabetic Foot Ulcers: A 
Technological Report (2017) 
3.3.1: Publication 6 Aim 
 The project associated with the publication had two primary aims.  The first 
was to develop a methodology for objectively collecting location-specific PA data 
within patients with or at-risk for DFU.  Although underpowered to conclusively 
determine whether differences exited, the project secondarily sought to make 
preliminary comparisons of location-specific PA profiles of patients with DFU versus 
those at-risk.   
3.3.2: Publication 6 Summary 
 Five participants at-risk for DFU (mean age= 55±11 years) and five with active 
DFU (mean age= 55±5 years) were recruited for the project.  All participants were 
community dwelling and did not rely on a wheelchair or other such device for 
mobility.  The at-risk participants were individuals at the highest possible risk for a 
future DFU, as they all had a prior history of DFU82-84.  At the time of enrolment all at-
risk participants had been ulcer free for ≥4 weeks.  The participants with active DFU 
were all utilizing different offloading modalities at the time of participation.  The list of 
modalities included: removable cast walker, diabetic shoe, wedge forefoot offloading 
shoe, soft cast paired with a walking boot and an accommodative surgical shoe.   
 Each participant was provided three devices to be used in monitoring their PA 
for 72hrs.  They were each given the same triaxial accelerometer based activity 
monitor (PAMSys; BioSensics, Cambridge, MA USA) as was used in Publication 5 of 
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this thesis.  As in that prior study, participants were asked to wear the activity 
monitor at all times (including sleeping episodes) with the exception of bathing 
periods.  Participants were also given a global positioning system (GPS) monitor 
(QStarz Travel recorder XT, Taipei, Taiwan).  Participants were advised to wear the 
GPS monitor on a belt or to keep it in a pocket of their pants.  Participants were also 
give a digital watch with a built in voice recorder.  The watch had an alarm that was 
activated every two hours between 10:00 and 20:00 each day.  Each time the alarm 
went off, participants were to use the watch’s voice recorder to log where they were 
and their current PA status (ex. walking, standing, sitting, etc.).   
 The collected GPS data was processed using an algorithm with episode 
detection rules based on spatial density and GPS data was classified as stops 
(staypoints) and moves (trips)85,86.  The time points at which stop and move episode 
began and ended were synchronized with the accelerometer’s activity data.  This 
synchronized GPS and activity data set was then compared to participants’ self-
reported daily logs using a custom LabVIEW 2015 program (National instruments, 
Austin, TX USA).  
 Across the subjects, the average proportion on the monitoring period for 
which the raw GPS data failed to provide a location was 13.1±20.4%.  Once the GPS 
data was processed and synchronized with the PA data, a GPS location was only 
lacking for 1.5±2.1% of the 72hr monitoring period.  After the self-reported location 
and activity logs from the digital watches were transcribed, it was found that 80±11% 
of the self-reported log entries had corresponding GPS locations.  The agreement 
between self-reported and GPS identified locations were in agreement 98±6% of the 
time.   
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 The participants with an active DFU participated in more weight bearing 
(standing and walking) PA at home than away from home (2.61±2.58 vs 0.91±0.51 
hrs/day, Cohen’s d = 1.1).  The at-risk participants had a very similar amount of 
weight bearing activity in their homes (2.53±1.58 hrs/day) as did the participants with 
active DFU, however, at-risk participants had substantially more weight bearing 
activity outside of their homes (2.1±1.50 vs. 0.91±0.51 hrs/day, Cohen’s d= 1.2).   
3.3.3: Publication 6 New Knowledge Gained  
No prior studies with a focus upon the diabetic foot have utilized methods 
integrating GPS provided location data with accelerometry-based PA data.  
Furthermore, although there have been PA studies of other populations that used 
GPS to monitor where PA was taking place, there was no consistent method of 
handling missing GPS data87.  Thus these prior studies typically limited their focus to 
PA conducted outdoors where GPS signals are most easily captured87-89.  Ignoring 
PA indoors would significantly limit the understanding of PA profiles of the diabetic 
foot population.  This is due to the fact that prior research that relied on patients 
maintaining a diary of their location33,90 (and the present study that objectively 
tracked participants’ location) found individuals with diabetic foot complications 
engage in more PA within their homes than outside of their homes.   
In addition to avoiding either unintentional or intentional errors in recall, the 
methods of the present project present another advantage over diary based methods 
of monitoring where PA occurs.  By using GPS to objectively monitor where patients 
are engaging in PA the methods developed in this project, could help prevent user 
‘fatigue.’  With diary methods, individuals must actively choose to log each trip and 
subsequent location they visit over the course of each day.  This could be perceived 
as burdensome especially for long duration (several days) monitoring periods.   
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Another benefit of this project is the fact that it included participants at-risk for 
DFU and participants with active DFU.  Both prior studies and current studies 
investigating PA and the diabetic foot tend to focus exclusively on either at-risk33,65,90 
patients or patients with active DFU29,91,92.  Although the present project was limited 
by two small samples of participants, it did allow for some preliminary direct 
comparisons between at-risk and actively ulcerated individuals.  As one might 
expect, the biggest difference between the two groups was the amount of PA 
undertaken outside of the home, with at-risk participants being more active away 
from home.  However, both groups had more total weight bearing time inside of the 
home than outside of the home.  The fact that all the participants with active DFU 
utilized different offloading devices could be seen as both a strength and a 
weakness.  In common practice, providers use a wide variety of offloading options in 
treating patients25,26.  Thus the inclusion of multiple devices in the present study 
tends to be representative of what happens in actual practice.  However, it is likely 
that the different devices had varying effects on user’s PA profiles and thus the 
varied offloading devices likely led to greater variability within the DFU participants 
than if a single device had been used by all participants.  Appropriately scaled future 
studies will be able to delve into investigating this. 
3.4: Publication 7 
Feasibility of a low intensity, technology-based intervention for increasing PA in 
adults at risk for a diabetic foot ulcer: a mixed methods study (2019) 
3.4.1: Publication 7 Aim 
 This study sought to conduct a feasibility assessment of a low-cost (from 
fiscal and personnel perspectives) PA intervention that utilized technology to help 
individuals at-risk for DFUs safely increase their activity levels.  
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3.4.2: Publication 7 Summary 
 Twelve participants (mean age= 60±9 years) were recruited to participate in 
the single arm investigation.  Inclusion criteria included: type 1 or type 2 diabetes; 
sedentary status (<3 bouts of 20 minutes or more of PA/week73); age ≥ 21years; 
DPN associated loss of protective sensation as identified by Semmes Weinstein 
Monofilament78  or vibration perception threshold93; HbA1c: 6.5-12.0%; primary care 
physician approval; and internet access.  Exclusion criteria included: active DFU; 
proliferative retinopathy; pregnancy or planning to become pregnant; inability to 
participate in PA without assistance; peripheral vascular disease (ankle brachial 
index < 0.6); and cardiovascular autonomic neuropathy (resting heart rate > 100 
bpm) or orthostatic hypotension)94,95.  
 Following completion of the informed consent process, the screening visit 
began with confirming volunteers met all inclusion/exclusion criteria.  Those that 
were found to be eligible completed assessments associated with the fabrication of 
custom made diabetic orthotics (TrueContour Therapeutic Insoles, Diapedia, State 
College, PA USA96).  The orthotics and diabetic shoes were provided to all 
participants to lessen the likelihood of DFU formation over the course of the 
intervention.  At the conclusion of the screening visit, participants were provided a 
GPS monitor (QStarz BT-Q1000XT, Taipei, Taiwan) and a triaxial PA monitor 
(PAMSys, BioSensics LLC, Newton, MA USA) to collect baseline location specific 
PA data for a one week period utilizing the methodology developed in association 
with Publication 6 of this thesis.  
 When participants returned for their next visit they were provided their custom 
insoles and diabetic shoes.  They were also provided a secondary means of 
reducing the risk of developing a DFU while in the trial.  Participants were given an 
Page | 37 
 
infrared digital thermometer and asked to check daily for signs of preulcerative 
inflammation97-100.  In addition to the thermometer they were given a diary instructing 
them to measure the temperature at six distinct locations on each foot and to 
determine the difference between corresponding sites on each foot.  If the difference 
was >2.2°C (4°F) for any location, participants were to reduce their activity and call 
the study nurse.  The last item given to participants at this visit was a personal 
commercial activity monitor (Fitbit Zip, San Francisco, CA USA).  In order to remotely 
monitor participants’ step counts, their devices were tied to a private online group to 
which the researchers had access.   
 The next four visits were used to implement the PA intervention.  Each of the 
visits was approximately 45minutes in length and all four were to be completed 
within a two week window.  The visits had four primary objectives: 1) initiate a 
personalized plan for increasing PA, 2) address PA concerns, 3) provision of 
education regarding PA behavioural strategies, and 4) provision of instruction for 
engaging in moderate intensity PA.  A clinical psychologist met with participants to 
introduce the behavioural strategies that were based upon content of the Diabetes 
Prevention Program and were rooted in social cognitive and self-determination 
theories101.  The moderate intensity PA consisted of walking on a treadmill at 40-
70% of each participant’s heart rate reserve and the duration of the first session 
walking bout was personalized to equate to approximately 50% of the participant’s 
daily step count in the preceding week.   
 Following the four in person interventional visits, participants transitioned to 
an eight-week period of remote support. During this period participants were sent a 
new daily step count goal each week that was calculated based upon the step count 
for the previous week. A modest increase of 50 steps/day/week was used.  Thus, if a 
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participant averaged 5,000 steps/day in week 1, they would be asked to walk 5,050 
steps/day in week 2.  In order to avoid excessively large week to week increases, if a 
participant exceed their goal for a particular week by more than 15% their following 
week’s goal would be capped at an increase of 15%.  So for a participant with a 
5,000 step/day goal that actually walked 6,000 steps/day, their goal for the following 
week would be 5,750 steps/day.  In addition to the weekly step count goals, 
participants also received tailored text messages incorporating behavioural 
strategies to help them overcome PA barriers.  Participants could also access the 
private Fitbit social network for the study and communicate with other participants.  
Research assistants also made daily posts on the network regarding behavioural 
strategies. 
 After the eight-week remote support period participants returned for a final 
study visit.  In addition to repeating baseline measures, a key informant interview 
was conducted at the visit.  The interviews were semi structured and focused on 
participants’ perceptions regarding the intervention.  Participants were also asked to 
rate the acceptability of the intervention using a modified version of the diabetes 
measurement and evaluation tool102.  The tool had participants rate various aspects 
of the intervention on a scale of 1 (very dissatisfied) to 5 (very satisfied).  Before 
leaving, participants were again provided the GPS monitor and triaxial PA monitor for 
monitoring location specific activity for one week.   
 Eleven of the twelve participants completed the final follow up visit and 
similarly only one participant failed to complete all four in person intervention visits 
(mean attendance rate = 97.9%).  Responses across the valuation tool indicated 
high treatment acceptance with a mean of 4.79±0.24 across all items.  Several items 
had a mean value of 5.0 (respect provided by your session leader; safety 
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precautions taken during the sessions; ability of the session leader to provide 
interesting information; discussions about monitoring PA).  The lowest scored item 
was ‘The convenience of the location’ for study visits (mean =4.18±1.08).  During the 
interviews all participants reported the intervention was useful for increasing PA 
engagement.  Additionally, 81% (9/11 participants) discussed benefits of setting 
goals and tracking PA.  That same proportion of participants also identified benefits 
of accountability and encouragement in association with the text messages or the 
personal activity monitor (Fitbit Zip).  Similar percentages of participants also found 
the safety measures of diabetic shoes/orthotics and temperature monitoring were 
beneficial.  
 The participants did report there was room for improvement with technological 
issues.  These issues were generally relative to the personal physical activity monitor 
with 45% (5/11 participants) indicating they had some trouble syncing their monitor 
to their computer, tablet or phone.  Another concern raised by 36% (4/11) of 
participants was a concern that the monitor did not always capture their activity.  Two 
of the common barriers to PA discussed during the interviews were pain (63%, 7/11 
participants) and weather (72%, 8/11 participants).  Accordingly, the month 
participants began the intervention was found to influence changes in daily step 
counts over the course of the intervention. 
 Although this feasibility study was underpowered to make any definitive 
conclusions regarding efficacy of the intervention, positive trends were identified.  
Although the increases from week to week in step count goals were modest, 
participants went from 3825±1504 steps/day to 4707±1152.  This equated to a 
medium effect size (d= 0.66).  In addition to the change in step count a small 
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improvement (d= 0.23) was seen in diabetes control with HbA1c values dropping 
from 8.47±1.34% at screening to 8.14±1.54% at end of study.   
3.4.3: Publication 7 New Knowledge Gained  
 In contrast to past investigations, the present study evaluated the feasibility of 
a less intensive and technology dependent behavioural intervention to increase PA 
profiles of persons at risk-for DFU.  Limiting the number of in person interventional 
visits to four proved to be manageable for participants as the average attendance 
rate for these visits was 97.9%.  Furthermore, the technological intervention during 
the remote monitoring period was positively reviewed by the vast majority of 
participants.  Although one prior PA intervention study in this population intentionally 
incorporated some behavioural change strategies72, that study’s strategies were 
limited to the use of social cognitive theory.  That theory proposes that the interplay 
of personal, behavioural and  environmental determinants influence health 
behaviours like PA103.  A weakness of social cognitive theory is its limited attention to 
types of motivation104-106.  The present study benefitted by incorporating strategies 
rooted in both social cognitive theory and self-determination theory107.  The self-
determination theory strategies focused on enhancing intrinsic motivation for PA and 
targeted use of extrinsic motivators.  Lastly the novel interventional program in the 
present study was the first to incorporate two key DFU prevention methods (plantar 
tissue temperature monitoring and plantar pressure optimized diabetic orthotics) to 
maximize participant safety during the intervention.   
3.5: Publication 8  
CLEAR Cleat: A Proof of Concept Trial of an Aerobic Activity Facilitator to Reduce 
Plantar Forefoot Pressures and the Potential in Those with Foot Ulcers (2008) 
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3.5.1: Publication 8 Aim 
 This study sought to serve as the initial proof-of-concept regarding a 
specialized cycling cleat that was intended to offload the forefoot of users.  The 
experimental cleat (CLEAR-Cleat108) was developed for the purpose of affording 
individuals with forefoot DFU the capacity to safely engage in lower extremity 
exercise.   
3.5.2: Publication 8 Summary 
 Ten young (aged 23.7±1.3 years) participants without any history of chronic 
medical conditions, such as diabetes or cardiopulmonary disease, were recruited.  
Participants each completed one study visit at a human performance laboratory.  
During the visit participants completed stationary recumbent bicycle trials with their 
dominant foot placed in three different footwear conditions: 1) standard bicycle cleat 
(Lifecycle 9500R; Life Fitness, Schiller Park, Illinois USA) and an athletic shoe; 2) 
CLEAR-Cleat and an athletic shoe; 3) CLEAR-Cleat and an offloading insole (DH 
Walker Insole, Össur, Reykjavík, Iceland).  The order of the footwear conditions was 
randomized for each participant.  The non-dominant foot utilized the standard bicycle 
cleat in tandem with an athletic shoe for all trials.  The CLEAR-Cleat was similar to a 
removable cast walker and included rigid struts 
extending up from the ankle region that allowed 
for fixation of the ankle at 90 degrees by a series 
of hook and loop straps (Figure 1).  The cleat 
differed from cast walkers in that it was 
truncated at the midfoot. The cleat was attached 
to the bicycle’s crank arm so that the heel was 
placed directly above the spindle, thus the 
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forefoot extended out anteriorly beyond the cleat-bicycle interface.   
 The resistance level of the stationary cycle was held consistent for each 
participant across the different footwear conditions.  During a preliminary warm-up 
period participants were asked to identify a comfortable resistance and cadence.  
During the subsequent cycling trials participants were asked to keep their rotations 
per minute (RPM) within a range of ±2 of their ‘preferred cadence.’  Each study trial 
consisted of cycling for seven minutes in the assigned footwear condition.  In order 
to assess the offloading of the foot, plantar pressure insoles (Pedar-X, Novel, 
Munich, Germany) were used to collect foot loading data for the final 10 seconds of 
each minute of cycling.  Plantar pressure data was collected bilaterally and was 
captured at 50Hz sampling frequency.  Additionally, participants’ heart rate and 
cycling RPM were recorded once per minute.  Heart rate was to be used as a 
measure of exertion while the RPM values were to be used to confirm whether the 
workload was consistent across conditions.   
 Variables analyzed from the plantar pressure insole data included peak 
pressure, pressure-time integral and contact area.  Masking software (Novel, 
Munich, Germany) was used to determine these variables’ values at the following 
regions of interest: forefoot (distal 47% of foot), rearfoot (proximal 53% of foot) and 
total foot.  Mean values for each 10 second collection of loading data were used for 
statistical analyses.  A repeated measures ANOVA was conducted for each region 
for each variable.  The ANOVA included main effects of: foot (dominant/CLEAR 
Cleat foot vs non-dominant/control foot), footwear condition, and time (minutes 1-7).  
Tukey’s Honestly Significant Difference test was used for post hoc analyses of main 
effects and interactions that were found to be significant.     
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 The plantar pressure insole data indicated the CLEAR Cleat significantly (p-
values for all of the following offloading differences discussed were <0.01) offloaded 
the forefoot.  When focusing on the foot that utilized the cleat, the contact area of the 
forefoot significantly decreased in a stepwise progression in going from athletic 
shoes paired with the bicycle’s standard cleat, to the athletic shoes paired with the 
CLEAR Cleat, to the offloading insole paired with the CLEAR Cleat.  These changes 
in forefoot contact area drove similar significant differences in total foot contact area 
for the foot using the cleat.  Although the contact area for the forefoot and total foot 
of the CLEAR Cleat foot changed, the contact area for the rearfoot did not 
significantly differ between the different footwear conditions.  Both the peak pressure 
and pressure-time integral data for the forefoot mimicked the contact area outcomes.  
Namely the offloading insole paired with CLEAR Cleat resulted in the least forefoot 
pressure, followed by the athletic shoe paired with the CLEAR Cleat, followed by the 
athletic shoe paired with the bicycle’s standard cleat.  Although the contact area of 
the rearfoot remained consistent across the conditions, the peak pressure and 
pressure-time integral values did change.  Both variables yielded their highest values 
in the athletic shoe paired with the CLEAR-Cleat, followed by the offloading insole 
paired with the CLEAR-Cleat, and the athletic shoe paired with the standard bicycle 
cleat.   
 The RPM did not differ significantly between the athletic shoe paired with the 
standard cleat (82±13), athletic shoe paired with the CLEAR Cleat (81±13) and the 
offloading insole paired with the CLEAR Cleat (81±12).  Since the resistance level 
was fixed across conditions, the lack of difference in RPM indicates the participants 
were exercising at a consistent workload across conditions.  Similarly to RPM, the 
percentage of age-predicted maximum heart rate maintained while cycling did not 
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differ across footwear conditions (athletic shoes & standard cleat= 60.9±3.0%; 
athletic shoe & CLEAR Cleat= 60.4±1.8%; offloading insole & CLEAR Cleat = 
61.1±3.6%).  The heart rate data suggest the cycling efficiency of participants did not 
change across conditions.   
3.5.3: Publication 8 New Knowledge Gained 
 This thesis has already discussed the importance of PA to managing diabetes 
and the fact that individuals at risk for DFU typically engage in insufficient amounts of 
PA.  Although extra caution to ensure healing is feasible when considering 
individuals with active DFU, it is still a major concern that individuals with active DFU 
have been objectively shown to be even more sedentary than at-risk individuals109. 
This is not a transient concern, as people with a history of DFU also self-report more 
sedentary behaviours than other cohorts of individuals with diabetes65.  The study 
associated with publication 8 provided initial support for a means to allow persons 
with active DFU to safely exercise.  The study was able to demonstrate initial proof-
of-concept regarding the ability to utilize a modified cycling interface to reduce 
physical stress to the forefoot during stationary cycling exercise.  This reduction was 
stable throughout the seven minute cycling bout.  Furthermore, the heart rate data 
indicates the CLEAR Cleat did not make it more challenging for participants to cycle.   
 
3.6: Publication 9  
Preliminary Evaluation of a Cycling Cleat Designed for Diabetic Foot Ulcers (2017) 
3.6.1: Publication 9 Aim 
 Having demonstrated initial proof-of-concept of the CLEAR Cleat in healthy 
individuals within Publication 8, this study sought to confirm repeatability of those 
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results in a group more representative of the population the cleat was designed for.  
In order to progress cautiously, Publication 9 involved individuals at-risk for DFU as 
opposed to individuals with active DFU.  In addition to confirming the offloading 
functionality of the cleat, Publication 9’s study also assessed the foot’s thermal and 
vascular responses to cycling with the CLEAR Cleat. Previous animal and human 
studies of aged and obese populations have provided data suggesting exercise may 
aid in wound healing110-112.  Increasing the temperature113,114 of the foot and the 
blood perfusion115,116 to the foot are two ways cycling could conceivably promote 
DFU healing.   
3.6.2: Publication 9 Summary 
 The study included fifteen adults with diabetes and that were at grade 1 or 
higher risk for developing a DFU according to the International Working Group on the 
Diabetic Foot’s risk classification system15.  Potential participants were excluded if 
they presently (or within the past 4 weeks) had an active DFU or if they were being 
treated for any chronic cardiovascular condition such as coronary heart disease or 
chronic obstructive pulmonary disease.  A sample size estimate with power of 80 
and α= 0.05 using peak pressure data from an offloading study by Lavery et al.46 
(expected mean difference between cycling conditions 40kPa and standard deviation 
of 20kPa) suggested 7 participants would be needed to confirm the cleat offloaded 
participants’ feet.  However, in order to explore the secondary outcomes of thermal 
and vascular responses to cycling, the sample size was set to 15 participants.   
 Within a single study visit each participant completed two 5-minute trials using 
the same stationary recumbent cycle as used in Publication 8.  In a randomized 
order across participants, one trial was done while cycling with bicycle’s standard 
pedals in tandem with standardized athletic shoes (New Balance, Boston, MA USA).  
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During the other cycling trial the right foot used the CLEAR Cleat in combination with 
the same offloading insole used in Publication 8 (DH Walker Insole, Össur, 
Reykjavík, Iceland).  During each participants’ first trial they were asked to identify a 
resistance level and cadence (RPM) they would feel comfortable maintaining for 30 
minutes.  They then used the same resistance and target cadence for cycling in the 
second trial.  Participants were given approximately 20 minutes to rest between the 
two trials.   
 As in Publication 8, plantar pressure insoles (Pedar-X; Novel, Munich, 
Germany) were used to compare peak pressure and pressure-time integral values 
between the two cycling conditions.  Pressure data was collected at 100 Hz.  Mean 
values for 10 consecutive revolutions near the end of each trial were utilized for 
analyses.  Masking software (MultiMask, Novel) was used to determine pressure 
values at the following distinct regions of the foot: heel (proximal 30% of foot), 
midfoot (intermediate 30% of foot) and forefoot (distal 40% of foot).  
 Data for the secondary outcomes of thermal and vascular responses to 
cycling were collected prior to initiating each cycling trial and immediately after 
concluding each trial.  Thermal response of the plantar aspect of the foot to cycling 
was assessed via infrared photography (Fluke; Everett, WA USA).  SmartView 3.0 
software (Fluke) was used in combination with a custom Matlab (MathWorks Inc, 
Natick, Massachusetts USA) code117 to process the thermal images.  Using the 
same definitions as were used with the plantar pressure data, the infrared foot 
images were divided into heel, midfoot and forefoot regions.  The vascular response 
to cycling was assessed via laser Doppler perfusion monitoring (Transonic Systems 
Inc, Ithaca, NY USA).  The flowprobe was attached to the plantar surface of the 
hallux prior to and at the conclusion of each cycling trial.  It was attached via an 
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adhesive sticker and an outline of sticker placement was made with a marker to 
ensure consistent placement of the probe for each measurement.  Each perfusion 
measurement was approximately 1 minute in duration.   
 All data analyses were limited to the right foot (the foot that utilized the 
CLEAR Cleat in one of the two trials).  Repeated measures ANOVA with main 
effects of foot region and footwear condition were used to analyse the peak pressure 
and pressure-time integral data sets.  Footwear condition and the interaction of 
footwear condition with foot region were found to be significant for both pressure 
outcomes.  Paired t-tests were used to look at the effect of footwear within each foot 
region.  Peak pressure and pressure-time integral outcomes were similar.  The 
values were significantly (p< 0.05) reduced in the forefoot and significantly increased 
in the heel while cycling with the CLEAR Cleat.  Values at the midfoot did not differ 
between cycling conditions.  A repeated measures ANOVA with main effects of time 
(pre versus post cycling) and footwear condition was used to assess the tissue 
perfusion data.  Only the main effect of time was found to be significant with hallux 
perfusion increasing 73.9% (4.0±1.2 versus 6.9±1.4 tissue perfusion units) over the 
course of trials.  Paired t-tests of pre versus post cycling temperature values and a 
repeated measures ANOVA for temperature change values with main effects of foot 
region and footwear condition did not find any significant differences in temperature 
values.   
3.6.3: Publication 9 New Knowledge Gained 
 This study demonstrated the CLEAR Cleat was able to offload the forefoot of 
individuals closely matching the population for which it was primarily intended to be 
used.  The pressure data indicate the cleat resulted in transferring pressure from the 
forefoot to the rear foot of individuals at-risk for DFU.  Thus a patient with an active 
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forefoot DFU should be able to exercise using the cleat without putting excessive 
stress on the DFU.  The peak pressure applied to the forefoot (10 kPa) while cycling 
with the CLEAR Cleat was well below values observed while walking in offloading 
devices (66-134 kPA)30,118.   
In addition to suggesting cycling with the cleat would be safe for a forefoot 
DFU, the study also suggested such exercise might aid DFU healing.  The noted 
increased microcirculation to the hallux suggests the excise may be able to increase 
oxygen and nutrient delivery to a forefoot DFU119.  Increased microcirculation could 
also lead to improved inflammatory responses at a DFU site.  Prior research in older 
mice has suggested an exercise induced anti-inflammatory response may improve 
wound healing120.  Increased/prolonged inflammation inhibits DFU healing121-123 and 
the anti-inflammatory cytokine IL-6 increases following exercise124,125.  In addition to 
producing IL-6, skeletal muscles release it into the blood stream when contracting124.  
Thus cycling with the CLEAR Cleat may lead to reductions in excessive inflammation 
at DFU sites. One limitation in interpreting the perfusion results of the study is the 
fact that no clinical assessments of peripheral arterial disease were completed on 
participants.  Thus it is unknown how the perfusion results might vary in individuals 
of differing levels of peripheral arterial disease.   
The study associated with Publication 8 failed to demonstrate any potential 
thermotherapeutic benefit of cycling with the CLEAR Cleat.  Prior studies have 
indicated externally warming the foot may aid DFU healing113,114.  The present study 
failed to identify any changes in foot temperature following the cycling bouts, 
therefore it provided no support to the premise that cycling could aid DFU healing by 
acting to increase the temperature of the foot.  However, it is possible future studies 
may find conflicting results.  The present study was limited to fairly short bouts of 5 
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minutes and a mean heart rate of 105 beats per minutes after cycling suggests 
participants were exercising at a modest exertion level.  It’s possible that changes in 
foot temperature could be elicited in future studies if the cycling bouts are longer or 
participants engage in a higher exertion level.    
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Chapter 4: Falls in Individuals at Risk for Diabetic Foot Ulcer Publications  
 
4.1: Critical Account of Falls Publications  
The final set of publications associated with this thesis centre on the problem 
of falls by patients with or at risk for DFU.  Fear of falling and injuries caused by a fall 
can significantly limit individuals’ PA levels.  Publication 10 of this thesis is a review 
publication that provides perspective on: the scope of the problem in older adults 
with diabetes, diabetes associated factors that predispose individuals to falling, and 
interventions to reduce individuals’ risk for falling42.  Some of the risk factors include 
decreased sensorimotor function, musculoskeletal deficiencies, pain, and therapeutic 
footwear (particularly devices used to offload active DFU).   
DPN is a key diabetic foot disease risk-factor for falling43.  Up to 50% of 
persons with diabetes will eventually develop signs and symptoms of DPN126.  In 
their seminal 1999 paper investigating DFU risk factors, Boyko et al. found sensory 
neuropathy was a highly significant predictor of DFU and noted it was unfortunately 
not reversible14.  Unfortunately, identification of an effective and reliable means of 
reversing loss of protective sensation remains elusive.  Despite referencing the 
importance of screening for loss of protective sensation, the American Diabetes 
Association’s 2018 compendium regarding diagnosing and managing diabetic foot 
complications makes no reference to treatment options for improving protective 
sensation127.  Preliminary results regarding an intervention that was intended to treat 
sensory neuropathy are presented within Publication 11 of this thesis43.   
Publication 11’s randomized controlled trial investigated the use of electrical 
stimulation therapy on plantar sensation and postural control of patients with DPN.  
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This study differed from prior studies that had used low level electrical128-130 or 
mechanical131 stimulation as low-level noise to ‘boost’ previously unperceivable 
external stimuli to the point where the external stimuli were recognized by sensory 
neurons.  The study associated with Publication 11 sought to determine whether 
routine provision of an electrical stimulation therapy would result in benefits that 
persisted in the absence of active stimulation.  There were some mixed results in 
regards to the sensation outcomes of vibration perception threshold testing and 
Semmes-Weinstein monofilament testing which were assessed in all 54 study 
participants.   The assessment of changes in postural control was a secondary 
exploratory outcome and was only measured in a subset of 13 participants.  Despite 
being an exploratory outcome, a statistically significant improvement in postural 
control was noted in association with the electrical stimulation therapy. This 
improved postural control indicated the therapy might help reduce fall risk in patients 
with DPN by improving peripheral nerve function.  However, additional studies with 
sufficiently long follow up periods to identify whether fall rates decline are required to 
validate this hypothesis. 
Publication 12 is the final falls related publication within this thesis and it dealt 
with the potential impact of DPN upon patients’ fear of falling44.  As referenced 
throughout the current chapter, DPN is a risk factor for falls.  While falls can result in 
immediate physical harm to the body, fear of falling can also be problematic.  A 
‘healthy’ concern for falling could lead individuals to adapt strategies intended to 
reduce their likelihood of falling, however, such fear can also result in a number of 
deleterious outcomes.  Anxiety, social withdrawal and restrictions in PA are all 
associated with concern for falling132-136.  Decreasing PA engagement may only 
serve to compound the actual risk of falling by resulting in physical deconditioning 
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that would limit individuals’ capacity to recover from challenges to their balance.  
Publication 12 reports findings of a study that assessed the association of DPN with 
fear of falling as well as whether fear of falling in this sample of individuals was 
associated with a number of gait parameters.  To date, research in this area remains 
minimal.   Publication 12’s results indicated that although older adults with diabetes 
were generally fearful of falling, the fear did not appear to be associated with severity 
of DPN.  However, multiple gait parameters were significantly associated with fear of 
falling.  The study concluded that fear of falling may be an unreliable indicator of fall 
risk.   
One limitation of Publication 12 was its reliance on a single clinical 
assessment (vibration perception threshold) of peripheral neuropathy.  Although 
nerve conduction velocity is considered the gold standard for diagnosing DPN, it is 
expensive, time consuming and often necessitates an additional clinic visit for 
patients137.  The American Diabetes Association’s Standards of Medical Care in 
Diabetes recommends sensation be tested as part of an annual physical 
examination of diabetic patients via Semmes Weinstein 10-g monofilament testing 
and a secondary test of  either vibration, temperature or pinprick sensation138.  Thus 
the use of vibration perception threshold testing in Publication 12 is well aligned with 
established standards of care, however, the study would have benefited from 
secondarily assessing participants’ sensation via Semmes Weinstein Monofilament.    
 
4.2: Publication 10  
A Growing Troubling Triad: Diabetes, Aging, and Falls (2013) 
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4.2.1: Publication 10 Aim 
 This review publication served to inform readers about factors that predispose 
individuals with diabetes to experience falls.  It also discussed the severity of falls 
within this population as well as means to mitigate falls within this vulnerable 
population.   
4.2.2: Publication 10 Summary 
 The introduction for Publication 10 began by reviewing the scope of the 
growing problem of falls within aging populations of western nations.  This included 
the annual cost of treating falls at the turn of the 21st century in the United Kingdom 
(£981/$1.9 billion US)139, Australia ($86.4 million/$66.1 million US)140 and the United 
States ($19.2 billion US)141.  In order to establish the scale of the problem within 
persons with diabetes, the annual incidence statistics for falls in persons with 
diabetes over 65 years old (39%)142 and persons over 55 years old (35%)143 were 
reported.  In addition to providing the incidence numbers, Publication 10 noted the 
fact that individuals with diabetes are at higher risk for falls than those without 
diabetes144,145   
 Publication 10 proceeded to review a number of factors that predispose 
persons with diabetes to experience falls.  The first risk factors to be discussed 
centred on neurological and musculoskeletal matters.  Individuals with diminished 
plantar sensation within their feet due to DPN have been found to have increased 
postural sway and reduced postural control63,146.  Furthermore, a study of over 9,000 
older women found that DPN and postural instability were the most important factors 
in explaining the relationship between diabetes and falls145.  Reduced PA and 
muscle strength have also been identified as contributing to altered gait patterns and 
an increased risk for falling by individuals with diabetes147,148.  Diminished plantar 
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flexion strength specifically, has been linked to increased centre of mass 
displacement which in turn results in decreased maximum forward reach distance in 
patients with diabetes149.  Thus it is not surprising that Macgilchrist et al. found 
ambulatory patients with diabetes whom were fallers had 40% less ankle plantar 
flexion strength than non-fallers143.  Additionally, older persons with diabetes and 
reduced muscle strength have been found to adopt slower walking speeds and 
increase the duration of their double support phase while walking which is likely in 
response to their increased instability150,151.  
 The association of foot/body pain and pharmacological complications with 
falls were reviewed next. Foot pain has been demonstrated to be a fall risk-factor in 
the broader population of community dwelling older adults152,153.  Unfortunately, in 
addition to losing the capacity to sense what should be painful stimuli, persons with 
diabetes are prone to developing peripheral neuropathic pain which occurs 
conversely in the absence of painful stimuli137.  In addition to this pain increasing fall 
risk, the treatment of the pain may also increase risk.  Peripheral neuropathic pain is 
commonly treated with psychotropic medications and these medications have been 
found to increase the risk for experiencing a fall147,154.  In addition to psychotropic 
medications, the total number of medications persons with diabetes are taking are a 
concern relative to falls.  Older adults with diabetes are prone to taking more 
prescription medications than their peers147 and patients with diabetes begin to have 
a heightened risk for falling when taking four or more prescription medications155. 
 The last risk factor for falls by persons with diabetes to be reviewed was 
offloading footwear.  As discussed throughout Chapter 2 of this thesis, reduced 
stability is a major concern in association with the provision of devices used to treat 
diabetic foot ulcers.  This is most evident in devices such as total contact casts and 
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cast walkers used to treat active diabetic foot ulcers156.  Normal gait and standing 
balance can both be challenged by these devices.  Some key reasons include the 
fixation of the ankle joint, the inclusion of a rocker bottom sole and inducement of a 
limb length discrepancy.  Findings from Publication 2 of this thesis further illuminated 
the relationship between ulcer offloading devices and balance by finding that self-
reported postural instability was negatively associated with offloading device 
adherence29.  Although to a lesser magnitude, footwear used to prevent diabetic foot 
ulcers may also contribute to reduced stability.  Rocker bottom soles may also be 
incorporated into preventative footwear and their convex design provides a smaller 
base of support to the foot.  Additionally, insoles that achieve their goal of reducing 
peak pressures may at the same time be reducing stability.  Such insoles increase 
contact area across the surface of the foot and transfer some load away from high 
stress areas such as the metatarsal heads to lower stress areas.  Van Deursen 
postulated reducing peak pressures and increasing contact area could either 
diminish or improve stability156.  He suggested it may result in greater cutaneous 
feedback through the recruitment of a greater number of sensory neurons.  
Conversely he noted that by reducing peak pressures across the foot, such insoles 
may decrease the likelihood of patients’ compromised neurons from registering foot 
loading (i.e. few neurons would receive a stimulus of sufficient magnitude to be 
detected).  Paton et al. appeared to provide support to the latter option in a study of 
patients with DPN that were assessed while wearing varied insole designs157.  They 
found that stability was diminished in insoles with arch fill that would serve to offload 
the forefoot by transferring some load to the midfoot.   
 After reviewing risk factors for falls, Publication 10 discussed the heightened 
risk for poor outcomes following a fall by persons with diabetes.  Unfortunately, 
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individuals with diabetes are at an increased risk of incurring a fracture in association 
with a fall158,159.  The increased risk for fractures by older adults with diabetes have 
been found to be associated with altered body composition, retinopathy, peripheral 
and autonomic neuropathy, hypoglycaemia and use of medications (particularly 
thiazolidinediones)160,161.  In addition to the heightened risk of experiencing a 
fracture, persons with diabetes are also prone to poorer recoveries in association 
with fractures.  Following a hip fracture; persons with diabetes have been found to 
have a worse length of stay efficiency in the hospital (measure of recovery per day in 
the hospital)162, worse functional outcome following rehabilitation163, and poorer 
health-related quality of life158.   
 The final section of Publication 10 discussed means to reduce fall-risk within 
persons with diabetes.  The publication primarily reviewed the results of studies 
investigating traditional strength, gait and balance training programs.  There is good 
evidence that these interventions can reduce fall-risk within diabetic individuals151,164-
166.  The fact that such results have been found within the specific population of 
persons with DPN is especially encouraging151,164,165.  Furthermore one study that 
compared diabetic individuals with a history of falling with three other groups 
(diabetic individuals with no history of falling, non-diabetic individuals with a history of 
falling and non-diabetic individuals without a history of falling) found the greatest 
improvements from their intervention were elicited in the diabetic individuals with a 
history of falling164.   
Unfortunately, at the time of the drafting of Publication 10 there was not much 
evidence regarding the capacity of strength, gait and balance training to reduce 
actual falls.  Studies designed to look at fall risk factors such as balance generally 
require smaller samples and shorter follow-up durations than studies seeking to 
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assess whether an intervention has reduced actual fall occurrence.  Confirming that 
an intervention has actually reduced falls requires a large enough sample to ensure 
enough events occur in the control condition in order to identify whether a clinically 
meaningful reduction has been achieved in the intervention group.  However, 
Publication 10 did discuss one study regarding the introduction of a strength and 
balance intervention for persons with DPN that did report falls data167.  This study 
identified no difference in falls between participants randomized to the intervention 
and a control group, however, there are several key limitations in the study that 
should be kept in mind.  Falls were not a primary outcome in the design of the study 
from which the data came.  The 2010 publication by Kruse et al. was a secondary 
analysis of data from a study focused on confirming whether an exercise intervention 
would increase PA engagement by participants.  Additionally there are compliance 
concerns within the study’s intervention group that may have contributed to the 
finding by the authors that “the intervention was insufficient to improve strength and 
balance in this population.”    
4.2.3: Publication 10 New Knowledge Gained  
 This single publication serves to educate clinicians, researchers and policy 
makers on: the scale of the problem of falls within persons with diabetes, the factors 
that predispose them to falling and means to combat diabetes related falls.  Due to 
the high number of falls, high likelihood of sustaining a serious fall injury and a worse 
prognosis for recovery; much more work is needed to reduce the fall related burden 
upon older persons with diabetes.  The impact of Publication 10 can in part be 
appreciated by the high number of times it has been cited since its publication in 
October of 2013 (76 times as of 3rd of July 2020 according to Google Scholar).   
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4.3: Publication 11 
A Novel Plantar Stimulation Technology for Improving Protective Sensation and 
Postural Control in Patients With Diabetic Peripheral Neuropathy- A Double-Blinded, 
Randomized Study (2013) 
4.3.1: Publication 11 Aim 
 The primary aim of Publication 11 was to evaluate the effect of an electrical 
stimulation therapy upon plantar sensation in patients with DPN.  The effect of the 
therapy upon participants’ postural control was a secondary outcome that was 
explored in a subset of study participants.   
4.3.2: Publication 11 Summary 
Fifty-four patients from four clinical centres were randomized to receive either 
an active electrical stimulator for the feet or a sham device (active n=25; sham 
n=29).  Inclusion criteria included a prior diagnosis of type 1 or type 2 diabetes and 
the presence of moderate DPN as defined by the inability to detect a 10g 
monofilament at between 1-3 sites out of 4 sites tested (hallux, 1st, 3rd, and 5th 
metatarsal heads)78.  Exclusion criteria included peripheral arterial disease, active 
diabetic foot ulcer, medical conditions sensitive to electrical disturbance (ex. 
implanted electrical device or epilepsy), and the inability to walk 100ft.    
The stimulation was provided while the feet rested in a footbath with a 
separate well for each foot.  Each well had to two electrode plates that were 
connected to an electrical stimulator.  The stimulation to the feet was transmitted to 
the feet via an aqueous solution in the footbath.  Patients were instructed to 
gradually increase the stimulator’s power at the start of each treatment session until 
they could either feel a comfortable tingling sensation or they reached 40% power 
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(however, none of the patients felt the stimulation prior to reaching 40%).  The 
stimulator provided 120Hz pulsed waveform current up to a maximum of 50mA.  
Participants in the sham group received a stimulator that was exactly the same in 
appearance to the one used by participants in the active group, however, it provided 
no stimulation to the feet.  Participants completed five 30-minute treatment sessions 
per week for 6 weeks.   
 The primary outcome of plantar foot sensation was evaluated by two 
assessments. Monofilament testing was conducted at the same 4 sites on each foot 
as was done for screening, however, each site was tested 3 times with each of the 
following grades of monofilament: 2, 4, 6, 8, 10 and 15g.  This resulted in a score of 
0-72 for each foot.  In addition to the extensive monofilament testing, vibration 
perception threshold was evaluated at the great toe using a biothesiometer93,168.   
After baseline testing, sensation was tested at week 2, 4 and 6 of the intervention.  
Sensation was also tested at a 6 week follow up visit for all subjects and at a 12 
week follow up for a subset of 20 subjects. 
In addition to the plantar sensation assessments, postural control was 
evaluated in a sub-sample of 13 participants (active n=5; sham n=8) from 2 of the 
study sites.  Centre of mass (COM) sway served as the measure of postural control.  
COM sway was quantified using a 2 sensor system (BalanSens, Biosensics LLC, 
Cambridge, MA USA).  Each sensor included a triaxial accelerometer, triaxial 
gyroscope and a triaxial magnetometer.  One sensor was placed onto a participant’s 
shin and the other on the participant’s lower back.  This allowed for the calculation of 
3D angles of the hip and ankle during quiet standing, which in turn allowed for COM 
sway to be calculated in both the anterior-posterior and medial-lateral directions63.  
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COM sway assessments were conducted in both eyes open and closed conditions 
for a standing duration of 30s in association with Romberg’s protocol169. 
Change scores (i.e. baseline vs. week 2, week 4, week 6 or follow up) for the 
monofilament and VPT data were each analysed via a two-way (treatment group x 
visit) repeated-measures ANOVA.  Significant (p<0.05) main effects or interactions 
were assessed by Sidak adjustment if more than two data groupings were compared 
or by independent t-tests if only two data groupings were to be compared.  The main 
effect of visit was significant for the monofilament data with scores significantly 
improved at treatment weeks 4 and 6 as well as at the 6 week follow up visit.  The 
monofilament data did not yield any significant findings in association with treatment 
group despite an apparent trend of a greater improvement in sensation within the 
active therapy group.  In contrast, there was a significant interaction of treatment 
group and visit for the VPT data.  At the visit following the 6th week of the 
intervention, the active therapy group had a significantly improved change in VPT (-
9.6 ± 15.9V) relative to baseline in comparison to the sham therapy group (0.1 ± 
19.5V).  Although the active group still had better VPT scores at follow-up, the 
difference with the sham group was no longer significant.   
A repeated-measures ANOVA was also used to assess the balance data.  A 
few participants were unable to maintain their balance during the eyes-closed 
condition.  As balance was a secondary outcome that was only assessed in 13 
participants, the inability of some participants to complete the eyes-closed trials 
forced the investigators to focus exclusively on the eyes-open trials.   There was no 
difference in COM sway between the groups at baseline.  However, at week 2 of the 
intervention the active therapy group demonstrated a significant reduction in COM 
sway relative to baseline.  This improvement in COM sway led to a significant 
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between-group difference at week 2.  This significant between-group difference in 
COM sway persisted throughout the rest of the intervention period as well as at the 
follow up visits 6 weeks and 12 weeks after the conclusion of the therapy.   
4.3.3: Publication 11 New Knowledge Gained  
 This preliminary investigation of electrical stimulation therapy provided via an 
aqueous solution to treat DPN, provided initial data regarding impact of the therapy 
upon protective sensation and postural stability.  Mixed outcomes were obtained with 
regards to the protective sensation measures.  While the therapy was found to 
improve VPT scores, it was not shown to improve the monofilament scores.  The 
monofilament scores were highly variable between subjects which contributed to the 
lack of between-group difference.  It’s possible that the high number of individual 
monofilament trials (72) per foot examined resulted in diminished concentration on 
the part of participants over the course of an exam.  If this did occur it would have 
confounded the results and possibly contributed to the variability between 
participants.  Even though the secondary outcome of postural control was limited to 
a small sample (active n=5; sham n=8), a statistically significant improvement was 
noted in the active therapy group relative to the sham therapy group.   
 The potential improvements in plantar sensation and balance indicate the 
electrical stimulation therapy may be able to reduce both diabetic foot ulcer risk as 
well as fall risk in patients with DPN.  What set’s this particular intervention apart 
from prior ones is the apparent lasting effect of the electrical stimulation therapy.  As 
discussed earlier in this chapter, several prior studies had looked at the use of low-
level electrical stimulation ‘noise’ to improve sensation by lowering the threshold 
required for an external stimulus to be perceived by the user128-130.  However, an 
obvious limitation to such an approach is that under this paradigm a benefit is only 
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provided while the individuals receive active stimulation.  Such an approach would 
face many hurdles in successful implementation within the daily life of persons with 
DPN.  In contrast, the electrical stimulation therapy evaluated in Publication 11 
proved to be feasibly administered in participants’ homes and provided a lasting 
benefit to nerve function beyond the period of active stimulation.  Additional research 
is needed to confirm whether this approach is able to reduce the incidence of 
diabetic foot ulcers and falls. 
4.4: Publication 12  
Fear of falling is prevalent in older adults with Diabetes Mellitus but is unrelated to 
level of neuropathy (2013) 
4.4.1: Publication 12 Aim 
 The aim of the study associated with Publication 12 was to assess whether 
DPN is associated with fear of falling with the aid of a validated measure for fear of 
falling.  Secondarily, the study sought to determine whether DPN and fear of falling 
were associated with gait parameters indicative of increased risk for falling.   
4.4.2: Publication 12 Summary 
Thirty-four community dwelling participants with diabetes aged 45 years or 
older (mean 67.6±9.2) were recruited.  Potential participants also needed to be able 
to walk further than 20m without the use of a walking aid.  Exclusion criteria included 
neurological conditions (other than DPN) and orthopaedic conditions involving the 
lower extremities that might impact gait (ex. amputation or joint replacement).   
Peripheral neuropathy was screened for via VPT values.  A biothesiometer 
(Xilas Medical, San Antonio, Texas USA) was used to identify each participant’s VPT 
(1-100V) at each hallux as described by Young et al.170.  The mean of the left and 
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right hallux VPT for each participant was used for analyses.  Fear of falling was 
quantified by having participants complete the Falls Efficacy Scale International 
survey.  This is a scale that was developed and validated by the Prevention of Falls 
Network Europe 171,172.  The sixteen item survey has a range of scores of 16 (no 
concern about falling) to 64 (severe concern about falling).   Participants’ gait was 
assessed with body worn inertial sensors173,174 (LEGSys, BioSensics LLC, 
Cambridge, Massachusetts) while participants walked 20m at their preferred speed.  
The LEGSys system consists of 2 sensors placed on the shins, 2 placed on the 
thighs and one sensor on the lower back.  Gait parameters captured included: stride 
velocity, stride length, stride time, double stance, intercycle gait speed variability and 
gait initiation (steps required to reach steady-state walking).   
Using a cut point of 25V for VPT as previously described170, 18 of the 
participants were classified as non-neuropathic (VPT=18.3±4.5V) and 16 were 
classified as neuropathic (VPT=49.7±21.9V).  A stepwise linear regression model 
was used to assess which gait variables were independently associated with 
neuropathy level (VPT scores).  Only those gait variables with a p≤0.2 in bivariate 
analyses were included in the multivariate analysis.  Two gait parameters associated 
with stability, double support time and gait initiation steps, were positively associated 
with level of neuropathy.  A secondary multivariate linear regression model was used 
to assess which variables were associated with fear of falling (FES-I scores).  
Despite the observed association for the gait parameters, no association was 
identified between peripheral neuropathy status and fear of falling.   
4.4.3: Publication 12 New Knowledge Gained   
 Prior to Publication 12, the literature regarding DPN and fear of falling was 
extremely limited.  There were, however, two publications that discussed an 
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association between DPN and fear of falling.   Powell et al. published a 
methodologically limited study that paired retrospectively collected clinical data 
regarding the use of phototherapy for DPN with a non-validated survey pertaining to 
history and fear of falling175.  Without providing clarity in the improvement, the 
authors indicate all patients in the assessed cohort experienced improved sensation 
following the phototherapy.  The authors also reported with a lack of clarity that 
patients in the cohort experienced a significant and ‘substantial’ reduction in 
neuropathic pain.  After retrospectively collecting neuropathy data from patient charts 
both prior to and after initiation of the phototherapy, the authors contacted the 
patients by telephone a single time.  They asked patients about their fall history and 
fear of falling before and after initiating the phototherapy.  The patients reported a 
reduced incidence and fear of falling after initiating phototherapy.  In another study 
that failed to use a validated fear of falling questionnaire and reported on painful 
DPN, Lalli et al.176 found painful DPN was associated greater fear of falling and gait 
alterations indicative of increased risk of falling.   
The results of Publication 12 provide further evidence of the association 
between DPN induced loss of protective sensation and heightened fall risk.  
Surprisingly, the study failed to identify a relationship between the clinical measure of 
loss of protective sensation and fear of falling.  This secondary finding suggests 
patients with reduced sensation due to DPN may not fully appreciate their own fall 
risk.  Although fear of falling was not tied to VPT scores, it is worth noting that across 
the entire sample fear of falling was highly prevalent.  Eighty-two percent of 
participants were classified as either moderately or highly concerned about falling.  
Another possible interpretation of Publication 12’s findings is that the gait 
adaptations found to be associated with neuropathy (ex. Increased double support 
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time) served as compensatory strategies that mitigated an increased fear of falling in 
association with neuropathy.   
 
  
Page | 66 
 
Chapter 5: Future Work & Conclusions  
5.1 Future Work 
The 12 publications upon which this thesis is based represent a body of work 
that has made significant advances regarding three interrelated themes across DFU 
care: offloading, PA engagement and understanding the heightened risk of falls.  
This work has addressed important clinical questions.  The addressment of those 
questions has in turn led to new questions and new avenues for pursuing scientific 
inquiry.  The synergistic nature of the studies presented in this thesis allows them to 
collectively serve as building blocks for new studies.  This chapter discusses one 
such ongoing project as well as several possible future lines of investigation.  
 Chapters 2-4 collectively laid out the case that postural instability and 
elevated falls risk contribute to non-adherence with offloading devices in patients 
with DPN.  While the offloading publications 3 and 4 provided some preliminary 
insight into the impact of these devices on stability, the impact of such devices on 
stability was not a primary outcome30,31.  Furthermore, these studies were limited to 
investigating stability during unchallenged indoor walking.  Generally the ultimate 
cause of falls is the failure to appropriately compensate for a loss of balance during a 
more demanding task than simple walking over level ground57.  A currently ongoing 
repeated measures study is seeking to determine whether the removable cast walker 
design features of walker height and imposed limb length discrepancy diminish 
compensatory responses to perturbations and therefore increase risk of falling.  
Within a single gait lab visit, participants are evaluated following waist-pull and 
treadmill imposed perturbations while wearing each of multiple offloading 
interventions.  Interim results have already been presented at the 8th International 
Symposium on the Diabetic Foot177.  The preliminary results presented suggest that 
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smaller perturbations are required to elicit a protective step from individuals with 
DPN while wearing a knee-high walker with no contralateral lift in comparison to an 
ankle-high walker paired with a contralateral limb lift.   
 The findings of this ongoing lab-based offloading study are expected to 
provide further justification for a longitudinal randomized controlled trial in patients 
with active DFU.  This would allow the investigation of whether prolonged use of 
different offloading devices lead to different adaptations by DFU patients over time.  
For example, it is hypothesized that adherence with a knee-high removable cast 
walker will decline more over time than adherence with an ankle-high removable cast 
walker.   
 Similarly, additional randomized controlled trials are anticipated to follow up 
other lines of investigation from this thesis.  Publication 7 presented the results of a 
single arm PA intervention for persons at-risk for DFU.  A future randomized 
controlled trial of longer duration than the original study is needed to confirm 
Publication 7’s promising results.  In addition to confirming the capacity of the 
intervention to impart meaningful user benefits, additional work is needed to evaluate 
the practicality of implementing the intervention in a clinical setting.  The initial study 
was primarily carried out in the context of a research laboratory which cannot be 
replicated on the scale needed to benefit the millions of individuals at risk for DFU.  
The CLEAR Cleat results of this thesis’ Publications 8 and 9 also provide sound 
justification for moving forward with a randomized controlled trial in patients with 
active DFU.   Those two publications demonstrated the CLEAR Cleat will allow users 
to engage in exercise incorporating the lower extremities without concomitantly 
placing significant load on a DFU.  In addition to determining whether prolonged use 
of the device elicits similar overall health benefits as other exercise interventions in 
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persons with diabetes, future studies should assess whether regular use of the 
CLEAR Cleat results in a difference in the healing trajectory of active DFU.   
5.2 Conclusions  
DFU are an underappreciated yet massively burdensome malady.  This thesis 
presents a substantial body of work pertaining to the three interrelated themes of 
offloading, monitoring and managing PA, and falls-risk in the context of persons with 
or at-risk for DFU.  At its core, the collective work pertains to helping diabetic foot 
patients adapt healthier physical activity profiles.  
Chapter 2 presented novel research that assessed offloading adherence and 
subsequent work to determine whether specific design features of removable cast 
walkers are likely to impact adherence28-31.  Although current guidelines recommend 
knee-high walkers as the preferred first line choice23, this thesis’ work found ankle-
high walkers yield similar offloading of the foot with greater comfort and reduced 
impact on users’ mobility.  Of the 12 publications upon which this thesis is based, 
Publication 4 is likely to have had the greatest immediate impact upon providers and 
patients.  In addition to looking at the impact of different cast walker heights on gait 
and comfort, it also assessed how those outcome variables were impacted by the 
provision of a contralateral lift to offset cast walker induced limb length 
discrepancies.  The outcomes of the study have direct relevance to clinicians’ 
treatment regimens as the study results can help care providers in selecting the best 
offloading options for their patients.  By jointly working with patients to take into 
account how offloading devices may impact gait and comfort, providers are likely to 
dispense offloading solutions that will offer the greatest likelihood for success for 
each patient.   
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The focus of Chapter 3 was PA and it began with two publications concerned 
with enhancing the means by which we quantify PA35,36.  The first highlighted 
standing-time’s substantial contribution to total daily weight bearing time in people 
with DPN35.  The second presented methodology for pairing geospatial and PA data 
in order to appreciate the association between one’s environment and level of PA36.  
The next set of Chapter 3 publications dealt with safely assisting individuals with 
diabetic foot disease become more physically active37-39.  Of those three 
publications, Publication 7 has the greatest potential for immediately affecting clinical 
care.  Although a larger randomized controlled trial is needed to confirm efficacy of 
the low-cost intervention for helping individuals at-risk for DFU to improve their 
physical activity profiles, a number of the study’s interventional components can 
presently be implemented by care providers.  For example, providers can discuss 
reasonable step count goals with patients.  Then the providers can utilize electronic 
health records systems’ patient portals (as an alternative to the text messaging used 
in the study) in order to maintain periodic contact regarding patients’ successes and 
barriers in reaching their physical activity goals.    
Chapter 4 concentrated on the association of the at-risk diabetic foot with 
accidental falls-risk, with the first publication reviewing the problem/evidence42.  The 
following publication evaluated an electrical stimulation therapy to treat the fall-risk 
factor of DPN43.  The final publication of the chapter (and thesis) presented a study 
that investigated the potential association between DPN and fear of falling44.  
Contrary to intuition, the study failed to identify an association between DPN and fear 
of falling.  Collectively, the work encompassing this thesis has made inroads in 
mitigating the global burden of DFU and has also set the stage for further lines of 
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investigation aimed towards increasing quality of life for those with diabetic foot 
disease.   
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